Next Article in Journal
Update on the Phylodynamic and Genetic Variability of Marburg Virus
Next Article in Special Issue
In Memory of the Virologist Jianguo Wu, 1957–2022
Previous Article in Journal
Viruses of Freshwater Mussels during Mass Mortality Events in Oregon and Washington, USA
Previous Article in Special Issue
BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Obituary

A Tribute to Professor Jianguo Wu

Guangdong Provincial Key Laboratory of Virology, Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China
Viruses 2023, 15(8), 1720; https://doi.org/10.3390/v15081720
Submission received: 6 August 2023 / Accepted: 9 August 2023 / Published: 11 August 2023
(This article belongs to the Special Issue In Memory of Jianguo Wu)
It has been a couple of months since Professor Jianguo Wu left us. Whenever I think about Professor Wu, his familiar voice and kind smile always appear in front of me. As a famous virologist, the former Director of the National Key Laboratory of Virology, Wuhan University and a Professor/Dean of Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, JINAN University, Professor Wu dedicated himself to virology research in China. He was a refined and engaging teacher, a charismatic professor, a gentle man and scholar. We deeply miss him for his wise words, encouragement, patient guidance and contagious singing.
It is a great fortune to have been taught and guided by Professor Wu throughout my academic life. I first met Professor Wu in 2006, when I was beginning my master’s study at Wuhan University, China. One of my first memories of Professor Wu was in the first supervision day, he asked me about my research interests in virology fields and future dreams. During our discussion, Professor Wu impressed me as a virologist with contagious enthusiasm and passion. Professor Wu had a strong faith that the future of students can be changed through patient education and kind guidance. As a supervisor, he encouraged and motivated you through the research. He always kept you on track to what was most novel and impactful among your studies. He was very generous to each student and provided us with various opportunities to attend academic conferences, summer schools and overseas studies. These academic activities and seminar training not only expanded our horizons, but also provided us with a diverse scope in fundamental and translational research, inspiring us in future research.
As a professor, he was always energetic and willing to embrace new challenges. He was open-minded to new technologies and never set limits on himself. In the beginning of Professor Wu’s research, by employing molecular biotechniques, he characterized DNA-dependent RNA polymerase and studied mechanisms regulating cell division and cell cycles from a tiny freshwater bacterium, Caulobacter [1,2,3]. After Professor Wu set up a lab at Wuhan University, China, he put extensive interests into human medical virology. Professor Wu and his group made fundamental progress in the mechanism of diverse viral infection, replication and pathogenesis, covering most common viruses [4,5,6,7,8,9,10,11,12,13,14,15,16] and viral coinfections [17,18,19,20] in humans. In addition, Professor Wu devoted himself to mechanism research of viral-induced oncogenesis and exploring virus-based cancer therapeutic strategies. His group explored regulatory mechanisms for Hepatitis B virus (HBV) and Hepatitis C virus (HCV)-driven liver tumorigenesis [21,22,23,24,25,26,27,28], and identified a novel HBx-interacting protein, YueF, functioning as a tumor suppressor [22]. One of Professor Wu’s greatest interests was to understand the regulatory mechanisms of host immunity and viral infections [29,30,31,32,33,34,35,36,37,38,39,40,41]. He and his collaborators identified multiple pathways in the regulation of inflammatory factors during viral infection [42,43,44,45,46]. His group also made impressive scientific discoveries in regulatory mechanisms of NLRP3 inflammasome activation during viral infection [47,48,49,50,51,52]. Moreover, Professor Wu always kept an open mind to new technologies and methodologies to develop antiviral agents and vaccines. He and his collaborators explored single-chain intracellular antibodies [53], natural medicinal compounds [54,55,56], nanomaterials [57], single-cell based siRNA screens [58,59,60] and vaccines [61,62] to inhibit or prevent viral replication. His vision and scientific attitude had a great influence on our future studies and career plans. Professor Wu proved to us that lifelong learning is a worthwhile process.
As a founding member, Professor Wu was appointed the Dean of the Institute of Medical Microbiology at JINAN University. He still kept a great enthusiasm to guide undergraduate and postgraduate students. He was happy to provide every bit of guidance and share his expertise in virology research. As a mentor, Professor Wu encouraged, motivated and supported you to become a better researcher in the scientific world. He helped his colleagues build goals and assisted them in focusing on their goals. He continuously gave you practical advice and shared knowledge to improve your professional and personal development. Meanwhile, Professor Wu was a patient listener who was willing to listen to your problems. He always offered you constructive feedback and guided you through your problems. With the support and guidance of Professor Wu, many of his students have gone on to have distinguished careers in scientific research fields, biomedical industries, public service and other fields.
Though I was his former master’s student and joined his lab at JINAN University for a brief time, I feel honored to have had the precious opportunity to learn from him. I was deeply influenced by him not just by his professional attitude, but by his charm and personality. Professor Wu was a well-known gentleman and scholar for his erudition, modesty, graciousness and generosity. Despite the many successes Professor Wu had achieved, he remained humble. In his work life, Professor Wu always kept great optimism among all the difficulties. He kept encouraging us that optimism brings hope. His positive life attitude greatly influenced the people that surrounded him. For the students who were struggling, he was always ready to lend a helping hand and willing to share his knowledge and wisdom. Whenever I want to give up on my study or work, his warm encouragement and determined face always reminds me to keep on going. What impressed us most was that Professor Wu was merciful man with a generous heart. During the COVID-19 outbreak, his group donated tons of disinfectant to universities and hospitals to support the protective measures. His charm and personality had enormous positive impacts on his students and colleagues. Under the influence of the holy spirit, more and more students are willing to engage in charitable activities and civic duties. We will always remember Professor Wu for the time we spent together.

Funding

This research received no external funding.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Wu, J.; Ohta, N.; Benson, A.K.; Ninfa, A.J.; Newton, A. Purification, characterization, and reconstitution of DNA-dependent RNA polymerases from Caulobacter crescentus. J. Biol. Chem. 1997, 272, 21558–21564. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Wu, J.; Ohta, N.; Newton, A. An essential, multicomponent signal transduction pathway required for cell cycle regulation in Caulobacter. Proc. Natl. Acad. Sci. USA 1998, 95, 1443–1448. [Google Scholar] [CrossRef] [PubMed]
  3. Wu, J.; Ohta, N.; Zhao, J.L.; Newton, A. A novel bacterial tyrosine kinase essential for cell division and differentiation. Proc. Natl. Acad. Sci. USA 1999, 96, 13068–13073. [Google Scholar] [CrossRef]
  4. Peng, G.; Yan, Y.; Zhu, C.; Wang, S.; Yan, X.; Lu, L.; Li, W.; Hu, J.; Wei, W.; Mu, Y.; et al. Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein. J. Virol. 2008, 82, 12487–12497. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Zhang, Q.; Gong, R.; Qu, J.; Zhou, Y.; Liu, W.; Chen, M.; Liu, Y.; Zhu, Y.; Wu, J. Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway. J. Virol. 2012, 86, 1544–1554. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Xu, W.; Ma, C.; Zhang, Q.; Zhao, R.; Hu, D.; Zhang, X.; Chen, J.; Liu, F.; Wu, K.; Liu, Y.; et al. PJA1 Coordinates with the SMC5/6 Complex to Restrict DNA Viruses and Episomal Genes in an Interferon-Independent Manner. J. Virol. 2018, 92, e00825-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Yang, Q.; Zhang, Q.; Zhang, X.; You, L.; Wang, W.; Liu, W.; Han, Y.; Ma, C.; Xu, W.; Chen, J.; et al. HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 to Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism. J. Virol. 2019, 93, e01607-18. [Google Scholar] [CrossRef] [Green Version]
  8. You, L.; Chen, J.; Liu, W.; Xiang, Q.; Luo, Z.; Wang, W.; Xu, W.; Wu, K.; Zhang, Q.; Liu, Y.; et al. Enterovirus 71 induces neural cell apoptosis and autophagy through promoting ACOX1 downregulation and ROS generation. Virulence 2020, 11, 537–553. [Google Scholar] [CrossRef]
  9. Ma, C.; Xu, W.; Yang, Q.; Liu, W.; Xiang, Q.; Chen, J.; Zhang, Q.; Liu, Y.; Wu, K.; Wu, J. Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome to Restrict Hepatitis B Virus Replication. J. Virol. 2020, 94, e01800-19. [Google Scholar] [CrossRef]
  10. Xiang, Q.; Wan, P.; Yang, G.; Huang, S.; Qin, M.; Yang, H.; Luo, Z.; Wu, K.; Wu, J. Beclin1 Binds to Enterovirus 71 3D Protein to Promote the Virus Replication. Viruses 2020, 12, 756. [Google Scholar] [CrossRef]
  11. Hu, D.; Wang, Y.; Li, A.; Li, Q.; Wu, C.; Shereen, M.A.; Huang, S.; Wu, K.; Zhu, Y.; Wang, W.; et al. LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination. Virulence 2021, 12, 1795–1807. [Google Scholar] [CrossRef] [PubMed]
  12. Wang, Y.; Li, Q.; Hu, D.; Gao, D.; Wang, W.; Wu, K.; Wu, J. USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination. Viruses 2021, 13, 2029. [Google Scholar] [CrossRef] [PubMed]
  13. Pan, P.; Li, G.; Shen, M.; Yu, Z.; Ge, W.; Lao, Z.; Fan, Y.; Chen, K.; Ding, Z.; Wang, W.; et al. DENV NS1 and MMP-9 cooperate to induce vascular leakage by altering endothelial cell adhesion and tight junction. PLoS Pathog. 2021, 17, e1008603. [Google Scholar] [CrossRef] [PubMed]
  14. Wang, W.; Chen, J.; Hu, D.; Pan, P.; Liang, L.; Wu, W.; Tang, Y.; Huang, X.R.; Yu, X.; Wu, J.; et al. SARS-CoV-2 N Protein Induces Acute Kidney Injury via Smad3-Dependent G1 Cell Cycle Arrest Mechanism. Adv. Sci. 2022, 9, e2103248. [Google Scholar] [CrossRef] [PubMed]
  15. Luo, Z.; Liang, Y.; Tian, M.; Ruan, Z.; Su, R.; Shereen, M.A.; Yin, J.; Wu, K.; Guo, J.; Zhang, Q.; et al. Inhibition of PIKFYVE kinase interferes ESCRT pathway to suppress RNA virus replication. J. Med. Virol. 2023, 95, e28527. [Google Scholar] [CrossRef] [PubMed]
  16. Pan, P.; Ge, W.; Lei, Z.; Luo, W.; Liu, Y.; Guan, Z.; Chen, L.; Yu, Z.; Shen, M.; Hu, D.; et al. SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication. Signal Transduct. Target. Ther. 2023, 8, 194. [Google Scholar] [CrossRef] [PubMed]
  17. Pan, Y.; Wei, W.; Kang, L.; Wang, Z.; Fang, J.; Zhu, Y.; Wu, J. NS5A protein of HCV enhances HBV replication and resistance to interferon response. Biochem. Biophys. Res. Commun. 2007, 359, 70–75. [Google Scholar] [CrossRef]
  18. Mu, Y.; Yu, Y.; Yue, X.; Musarat, I.; Gong, R.; Zhu, C.; Liu, Y.; Liu, F.; Zhu, Y.; Wu, J. The X protein of HBV induces HIV-1 long terminal repeat transcription by enhancing the binding of C/EBPbeta and CREB1/2 regulatory proteins to the long terminal repeat of HIV-1. Virus Res. 2011, 156, 81–90. [Google Scholar] [CrossRef]
  19. Qu, J.; Yang, Z.; Zhang, Q.; Liu, W.; Li, Y.; Ding, Q.; Liu, F.; Liu, Y.; Pan, Z.; He, B.; et al. Human immunodeficiency virus-1 Rev protein activates hepatitis C virus gene expression by directly targeting the HCV 5’-untranslated region. FEBS Lett. 2011, 585, 4002–4009. [Google Scholar] [CrossRef] [Green Version]
  20. Kang, L.; Luo, Z.; Li, Y.; Zhang, W.; Sun, W.; Li, W.; Chen, Y.; Liu, F.; Xia, X.; Zhu, Y.; et al. Association of Vpu with hepatitis C virus NS3/4A stimulates transcription of type 1 human immunodeficiency virus. Virus Res. 2012, 163, 74–81. [Google Scholar] [CrossRef]
  21. Wei, W.; Huang, W.; Pan, Y.; Zhu, F.; Wu, J. Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras. Cancer Lett. 2006, 244, 119–128. [Google Scholar] [CrossRef] [PubMed]
  22. Huang, J.; Wu, K.; Zhang, J.; Si, W.; Zhu, Y.; Wu, J. Putative tumor suppressor YueF affects the functions of hepatitis B virus X protein in hepatoma cell apoptosis and p53 expression. Biotechnol. Lett. 2008, 30, 235–242. [Google Scholar] [CrossRef] [PubMed]
  23. Liu, Q.; Chen, J.; Liu, L.; Zhang, J.; Wang, D.; Ma, L.; He, Y.; Liu, Y.; Liu, Z.; Wu, J. The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production. J. Biol. Chem. 2011, 286, 17168–17180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Xu, Y.; Yang, Y.; Cai, Y.; Liu, F.; Liu, Y.; Zhu, Y.; Wu, J. The X protein of hepatitis B virus activates hepatoma cell proliferation through repressing melanoma inhibitory activity 2 gene. Biochem. Biophys. Res. Commun. 2011, 416, 379–384. [Google Scholar] [CrossRef] [PubMed]
  25. Lu, L.; Zhang, Q.; Wu, K.; Chen, X.; Zheng, Y.; Zhu, C.; Wu, J. Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK/p38/NF-kappaB signal cascade. Cancer Lett. 2015, 356, 470–478. [Google Scholar] [CrossRef] [PubMed]
  26. Zhang, R.; Cao, Y.; Bai, L.; Zhu, C.; Li, R.; He, H.; Liu, Y.; Wu, K.; Liu, F.; Wu, J. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades. Mol. Carcinog. 2015, 54, 1554–1566. [Google Scholar] [CrossRef] [PubMed]
  27. Zhang, Q.; Wei, L.; Yang, H.; Yang, W.; Yang, Q.; Zhang, Z.; Wu, K.; Wu, J. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection. Cancer Lett. 2016, 371, 107–116. [Google Scholar] [CrossRef] [Green Version]
  28. Liu, Z.; Dai, X.; Wang, T.; Zhang, C.; Zhang, W.; Zhang, W.; Zhang, Q.; Wu, K.; Liu, F.; Liu, Y.; et al. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells. Cancer Lett. 2017, 400, 149–160. [Google Scholar] [CrossRef]
  29. Chen, Y.; Chen, J.; Wang, H.; Shi, J.; Wu, K.; Liu, S.; Liu, Y.; Wu, J. HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog. 2013, 9, e1003248. [Google Scholar] [CrossRef] [Green Version]
  30. Bai, L.; Zhang, W.; Tan, L.; Yang, H.; Ge, M.; Zhu, C.; Zhang, R.; Cao, Y.; Chen, J.; Luo, Z.; et al. Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication. J. Mol. Cell Biol. 2015, 7, 543–556. [Google Scholar] [CrossRef] [Green Version]
  31. Zhang, X.; Zhu, C.; Wang, T.; Jiang, H.; Ren, Y.; Zhang, Q.; Wu, K.; Liu, F.; Liu, Y.; Wu, J. GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation. PLoS Pathog. 2017, 13, e1006321. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Luo, Z.; Ge, M.; Chen, J.; Geng, Q.; Tian, M.; Qiao, Z.; Bai, L.; Zhang, Q.; Zhu, C.; Xiong, Y.; et al. HRS plays an important role for TLR7 signaling to orchestrate inflammation and innate immunity upon EV71 infection. PLoS Pathog. 2017, 13, e1006585. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Ge, M.; Luo, Z.; Qiao, Z.; Zhou, Y.; Cheng, X.; Geng, Q.; Cai, Y.; Wan, P.; Xiong, Y.; Liu, F.; et al. HERP Binds TBK1 To Activate Innate Immunity and Repress Virus Replication in Response to Endoplasmic Reticulum Stress. J. Immunol. 2017, 199, 3280–3292. [Google Scholar] [CrossRef] [PubMed]
  34. Chen, J.; Xu, W.; Chen, Y.; Xie, X.; Zhang, Y.; Ma, C.; Yang, Q.; Han, Y.; Zhu, C.; Xiong, Y.; et al. Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 to Repress IFN/JAK/STAT Signaling. J. Virol. 2017, 91, e01824-16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Chen, K.; Xiao, F.; Hu, D.; Ge, W.; Tian, M.; Wang, W.; Pan, P.; Wu, K.; Wu, J. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-beta Production. Viruses 2020, 13, 47. [Google Scholar] [CrossRef] [PubMed]
  36. Yang, Y.; Liu, W.; Hu, D.; Su, R.; Ji, M.; Huang, Y.; Shereen, M.A.; Xu, X.; Luo, Z.; Zhang, Q.; et al. HIV-1 Nef Interacts with LMP7 to Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation. mBio 2020, 11, e02221-19. [Google Scholar] [CrossRef] [PubMed]
  37. Su, R.; Shereen, M.A.; Zeng, X.; Liang, Y.; Li, W.; Ruan, Z.; Li, Y.; Liu, W.; Liu, Y.; Wu, K.; et al. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine. mBio 2020, 11, e02540-20. [Google Scholar] [CrossRef]
  38. Tian, M.; Liu, W.; Zhang, Q.; Huang, Y.; Li, W.; Wang, W.; Zhao, P.; Huang, S.; Song, Y.; Shereen, M.A.; et al. MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway. Cell Rep. 2020, 33, 108297. [Google Scholar] [CrossRef]
  39. Li, A.; Wang, W.; Wang, Y.; Chen, K.; Xiao, F.; Hu, D.; Hui, L.; Liu, W.; Feng, Y.; Li, G.; et al. NS5 Conservative Site Is Required for Zika Virus to Restrict the RIG-I Signaling. Front. Immunol. 2020, 11, 51. [Google Scholar] [CrossRef]
  40. Shang, J.; Zheng, Y.; Mo, J.; Wang, W.; Luo, Z.; Li, Y.; Chen, X.; Zhang, Q.; Wu, K.; Liu, W.; et al. Sox4 represses host innate immunity to facilitate pathogen infection by hijacking the TLR signaling networks. Virulence 2021, 12, 704–722. [Google Scholar] [CrossRef]
  41. Tian, M.; Liu, W.; Li, X.; Zhao, P.; Shereen, M.A.; Zhu, C.; Huang, S.; Liu, S.; Yu, X.; Yue, M.; et al. HIF-1alpha promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct. Target. Ther. 2021, 6, 308. [Google Scholar] [CrossRef] [PubMed]
  42. Yan, X.; Hao, Q.; Mu, Y.; Timani, K.A.; Ye, L.; Zhu, Y.; Wu, J. Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein. Int. J. Biochem. Cell Biol. 2006, 38, 1417–1428. [Google Scholar] [CrossRef]
  43. Zhang, X.; Wu, K.; Wang, D.; Yue, X.; Song, D.; Zhu, Y.; Wu, J. Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB. Virology 2007, 365, 324–335. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Zhu, C.; Zhang, R.; Liu, L.; Rasool, S.T.; Mu, Y.; Sun, W.; Hao, Q.; Liu, F.; Zhu, Y.; Wu, J. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin. Immunol. 2009, 131, 92–97. [Google Scholar] [CrossRef] [PubMed]
  45. Yu, Y.; Gong, R.; Mu, Y.; Chen, Y.; Zhu, C.; Sun, Z.; Chen, M.; Liu, Y.; Zhu, Y.; Wu, J. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2. J. Immunol. 2011, 187, 4844–4860. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Cao, Y.; Zhang, R.; Zhang, W.; Zhu, C.; Yu, Y.; Song, Y.; Wang, Q.; Bai, L.; Liu, Y.; Wu, K.; et al. IL-27, a cytokine, and IFN-lambda1, a type III IFN, are coordinated to regulate virus replication through type I IFN. J. Immunol. 2014, 192, 691–703. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Wang, W.; Xiao, F.; Wan, P.; Pan, P.; Zhang, Y.; Liu, F.; Wu, K.; Liu, Y.; Wu, J. EV71 3D Protein Binds with NLRP3 and Enhances the Assembly of Inflammasome Complex. PLoS Pathog. 2017, 13, e1006123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Wang, W.; Li, G.; De, W.; Luo, Z.; Pan, P.; Tian, M.; Wang, Y.; Xiao, F.; Li, A.; Wu, K.; et al. Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1beta secretion. Nat. Commun. 2018, 9, 106. [Google Scholar] [CrossRef] [Green Version]
  49. Pan, P.; Zhang, Q.; Liu, W.; Wang, W.; Lao, Z.; Zhang, W.; Shen, M.; Wan, P.; Xiao, F.; Liu, F.; et al. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation to Induce Vascular Leakage in Mice. J. Virol. 2019, 93, e00996-19. [Google Scholar] [CrossRef] [Green Version]
  50. Wang, W.; Hu, D.; Wu, C.; Feng, Y.; Li, A.; Liu, W.; Wang, Y.; Chen, K.; Tian, M.; Xiao, F.; et al. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog. 2020, 16, e1008335. [Google Scholar] [CrossRef] [Green Version]
  51. Pan, P.; Shen, M.; Yu, Z.; Ge, W.; Chen, K.; Tian, M.; Xiao, F.; Wang, Z.; Wang, J.; Jia, Y.; et al. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat. Commun. 2021, 12, 4664. [Google Scholar] [CrossRef] [PubMed]
  52. Wan, P.; Zhang, S.; Ruan, Z.; Liu, X.; Yang, G.; Jia, Y.; Li, Y.; Pan, P.; Wang, W.; Li, G.; et al. AP-1 signaling pathway promotes pro-IL-1beta transcription to facilitate NLRP3 inflammasome activation upon influenza A virus infection. Virulence 2022, 13, 502–513. [Google Scholar] [CrossRef] [PubMed]
  53. Mukhtar, M.M.; Li, S.; Li, W.; Wan, T.; Mu, Y.; Wei, W.; Kang, L.; Rasool, S.T.; Xiao, Y.; Zhu, Y.; et al. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription. Int. J. Biochem. Cell Biol. 2009, 41, 554–560. [Google Scholar] [CrossRef] [PubMed]
  54. Pang, R.; Tao, J.Y.; Zhang, S.L.; Chen, K.L.; Zhao, L.; Yue, X.; Wang, Y.F.; Ye, P.; Zhu, Y.; Wu, J.G. Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro. Evid. Based Complement. Altern. Med. 2011, 2011, 939205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Zhang, W.; Tao, J.; Yang, X.; Yang, Z.; Zhang, L.; Liu, H.; Wu, K.; Wu, J. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem. Biophys. Res. Commun. 2014, 449, 307–312. [Google Scholar] [CrossRef] [PubMed]
  56. Chen, H.; Lao, Z.; Xu, J.; Li, Z.; Long, H.; Li, D.; Lin, L.; Liu, X.; Yu, L.; Liu, W.; et al. Antiviral activity of lycorine against Zika virus in vivo and in vitro. Virology 2020, 546, 88–97. [Google Scholar] [CrossRef] [PubMed]
  57. Rao, L.; Wang, W.; Meng, Q.F.; Tian, M.; Cai, B.; Wang, Y.; Li, A.; Zan, M.; Xiao, F.; Bu, L.L.; et al. A Biomimetic Nanodecoy Traps Zika Virus to Prevent Viral Infection and Fetal Microcephaly Development. Nano Lett. 2019, 19, 2215–2222. [Google Scholar] [CrossRef]
  58. Wu, K.; Mu, Y.; Hu, J.; Lu, L.; Zhang, X.; Yang, Y.; Li, Y.; Liu, F.; Song, D.; Zhu, Y.; et al. Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system. Antivir. Res. 2007, 74, 142–149. [Google Scholar] [CrossRef]
  59. Zhang, X.; Wu, K.; Yue, X.; Zhu, Y.; Wu, J. Inhibition of SARS-CoV gene expression by adenovirus-delivered small hairpin RNA. Intervirology 2007, 50, 63–70. [Google Scholar] [CrossRef]
  60. Tong, W.P.; Zhou, Y.; Wang, X.; Yang, F.; Wu, K.L.; Wu, J.; Zhang, Y. An accurate quantitative method for screening effective siRNA probes targeting a Hepatitis B virus transcript in single living cells. Biochem. Biophys. Res. Commun. 2008, 367, 866–873. [Google Scholar] [CrossRef]
  61. Feng, Y.; Wang, S.; Luo, F.; Ruan, Y.; Kang, L.; Xiang, X.; Chao, T.; Peng, G.; Zhu, C.; Mu, Y.; et al. A novel recombinant bacterial vaccine strain expressing dual viral antigens induces multiple immune responses to the Gag and gp120 proteins of HIV-1 in immunized mice. Antivir. Res. 2008, 80, 272–279. [Google Scholar] [CrossRef]
  62. Lei, Z.; Zhu, L.; Pan, P.; Ruan, Z.; Gu, Y.; Xia, X.; Wang, S.; Ge, W.; Yao, Y.; Luo, F.; et al. A vaccine delivery system promotes strong immune responses against SARS-CoV-2 variants. J. Med. Virol. 2023, 95, e28475. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chen, X. A Tribute to Professor Jianguo Wu. Viruses 2023, 15, 1720. https://doi.org/10.3390/v15081720

AMA Style

Chen X. A Tribute to Professor Jianguo Wu. Viruses. 2023; 15(8):1720. https://doi.org/10.3390/v15081720

Chicago/Turabian Style

Chen, Xin. 2023. "A Tribute to Professor Jianguo Wu" Viruses 15, no. 8: 1720. https://doi.org/10.3390/v15081720

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop